Member Info for JimiHendrix

We’ll have to wait and see but obviously if it’s shared out evenly then the programme we’re likely involved in would receive £3.3m. If we’re involved I would expect the company to RNS it soon, I’d be very surprised if we’re not involved.

Also, as well as NICE, I believe we’re expecting Stroke marker test launch in the next 2 weeks. An exciting week ahead!

Genedrive must surely be involved in this. A slice of this £100m grant might negate the need for a traditional fundraise.

“The Development and Validation of Technology for Time Critical Genomic Testing (DEVOTE) programme will be led by The University of Manchester. It focuses on biomarkers, which are chemicals or signals in the body which can be used to diagnose disease or predict future health. At the moment there is a bottleneck between the discovery of new biomarkers, and their use as a tool to help patients. DEVOTE aims to change all that by developing raid tests which can be used at the bedside by clinicians. This will be done through a partnership between the University, Health Innovation Manchester and local businesses. Greater Manchester is already a leader in this field and the new funding will create a legacy not only in people’s health but in a culture which makes new advances in future years.”

Any NHS trust can take up the test after NICE approval, there are no more approval steps or testing stages needed, it’s all been completed over the past couple of years.

I’m expecting European sales off the back of the NICE guidelines, they’re clearly a well respected medical authority world wide. Very exciting seeing the frequency of new distribution deals being established knowing the lengthy process of due diligence the company have undertaken this time round, having learned from past experiences.

In terms of share price I think there’s a real chance of reaching 60-80p over the next 2 weeks and possibly higher on the actual RNS day. Any good European deals could potentially push company funds past June, things are certainly hotting up.

Spotted those too, they show up on my L2... maybe refresh.

That was a premium to the shown asking price, signalling the high demand. We’ll probably see tomorrow’s opening price at 37.5.

Actually we did hit a price over 37p… £7k bought at 37.41 in the last minute.

14-Mar-23 16:29:18 37.41 19,000 Buy* 7,108

Announcing Antisel as our exclusive distribution partner for Greece. With over 50 decades of service, Antisel is a leading international organisation for the provision of innovative solutions through their extensive portfolio of quality brands #GDR #partnership #genedrive #POCT

Getting very exciting here!

We usually have a ‘notice of results’ RNS several weeks before the results so I’m not expecting results until April now as we haven’t had the notice yet, which is later than usual.

Interesting, it would be good to the trusts plans for when NICE final recommendation is given. Will they be acquiring the POCT equipment to take part in early access, or will they wait until the longer feedback trial stage is complete when it will hopefully become routine to make the test available.

We will see a huge spike here, however we’re not waiting on approval from MHRA. AIHL is already approved to be used, what we’re waiting for is NICE to publish their guidance following the recent consultation period. This is expected end of March.

He’s not wrong!…

Meanwhile, investors should continue monitoring “Genedrive shares despite the lack of frequent updates from the company. We could see a massive spike higher once the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approves the test.”

Also remember the long due diligence process the company has carried out vetting for suitable distributors this time round. If we see simultaneous rollout in Europe and the NHS beginning on NICE publication the share price will explode.

I think we’ll see European sales after NICE publication. I can imagine some people seeing these new distributors and remembering the POC test and how they amounted to nothing. AIHL is completely different, the test is a no brainer. Sales teams have been working hard in Europe the past year, and if several countries decide to roll out the test after NICE decision we could be in for a nice surprise indeed!

One of the large delayed buys was nearly £70k and definitely a buy at 11.875 at 15:15 yesterday. Massive buying demand this afternoon. Very very cheap at this price, market makers will take it up when they’re ready.

A lot of large delayed buys showing up again after close. I think somebody is loading up heavily and the share price has been manipulated down to fill the orders.

Seems it’s traders, imo probably market makers as most of the big trades are being hidden and revealed later. It will shoot up again soon, very cheap still at the moment. when they’re trying to take it down they often make it impossible to buy.

Lots of large delayed buys going through. Explains the difficulty in buying earlier.

No, the strange thing with that is it’s been very easy to get a quote to sell but very difficult to get one to buy… which suggests someone is trying buy a large amount imo and mms are trying to encourage sells.

Accounts due maybe putting people off until after?

Actually with IG to my surprise you can dummy sell (or get a quote for) a greater number of shares than you own. On previous platforms I’ve used it’s not been possible but I tried it with IG a couple of weeks ago when it was mentioned here and sure enough it is.